This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,005.85, is for the provision of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid dependence and alcohol dependence. The contract is a firm fixed-price, delivery order type, with an ultimate completion date of March 26, 2025. This contract is not associated with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,236.31, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has a firm fixed price pricing type and a completion date of November 22, 2024. It is not designated as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of alcohol and opioid dependence. The contract has a ceiling value of $1,001.17 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition. The contract is part...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract, valued at $13,639.29, is a firm fixed-price agreement with a completion date of August 6, 2024. It is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $6,032.25, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a specialty pharmaceutical product. This delivery order is issued under an indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, which has a...
This federal contract award, valued at $1,001.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid and alcohol dependence. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,988.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 14, 2023. This award is not associated with a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract is a Firm Fixed Price arrangement with a ceiling value of $4,734.26 and an ultimate completion date of August 20, 2024. The contract is not set aside for any specific business category. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medical product, at a ceiling value of $3,003.51. The contract has a firm fixed-price pricing type and a period of performance ending on February 13, 2025. This award does not have a set-aside designation, indicating...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vivitrol 380 mg vials and diluents, a medication used for the treatment of alcohol and opioid dependence. The contract has a ceiling value of $2,047.52 and is a firm fixed price arrangement. The ultimate completion date for this delivery order is March 28, 2023. AmerisourceBergen holds a larger Indefinite...